Kyle Keese Net Worth & Insider Trades
Kyle Keese - EVP, Emergent Biosolutions Inc
What is Kyle Keese's Net Worth?
The current estimated net worth of Emergent Biosolutions Inc's EVP, Kyle Keese, is estimated to be about $663.13K . Kyle Keese owns about 9,070 units of Emergent Biosolutions Inc common stock. In the last 5 years at Emergent Biosolutions Inc, Kyle Keese has sold an estimated value of $647.29K worth.
What is Kyle Keese's Past Insider Trading?
Kyle Keese's largest purchase order was 5,955 units , worth over $16.32K on June 14, 2007. Kyle Keese's largest sale order was 9,900 units , worth over $199.09K on November 12, 2008. In total, Kyle Keese has made about 24 transactions over 5 years of their time at Emergent Biosolutions Inc. Kyle Keese usually trades in June, with the busiest year in 2007. The most recent transaction was a sale order of 5,276 units , worth over $92.33K on August 25, 2010.
Kyle Keese
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Kyle Keese's' Mailing Address?
- Mailing address is 2273 Research Blvd, Suite 400 Rockville MD 20850 MD
Emergent Biosolutions Inc Executive Compensation
Name |
Year
|
Salary
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Fuad El-Hibri | 2020 | $1,192,202 | $1,200,046 | $815,051 | - | $6,185 | $3,213,484 |
| Fuad El-Hibri | 2019 | $1,131,577 | $1,099,949 | $773,813 | - | $4,723 | $3,010,062 |
| Fuad El-Hibri | 2018 | $1,047,031 | $957,456 | $957,481 | - | $8,250 | $2,970,218 |
| Robert Kramer | 2020 | $893,860 | $2,050,007 | $1,392,416 | $1,225,020 | $8,675 | $5,569,978 |
| Robert Kramer | 2019 | $678,021 | $1,439,958 | $1,012,999 | $557,108 | $5,735 | $3,693,821 |
| Robert Kramer | 2018 | $549,047 | $649,930 | $649,980 | $538,807 | $8,983 | $2,396,747 |
| Richard Lindahl | 2020 | $549,390 | $749,998 | $509,425 | $462,012 | $10,475 | $2,281,300 |
| Richard Lindahl | 2019 | $514,826 | $619,984 | $436,154 | $297,429 | $9,104 | $1,877,497 |
| Richard Lindahl | 2018 | $365,393 | $557,438 | $351,101 | $330,007 | $8,514 | $1,612,453 |
| Adam Havey | 2020 | $546,507 | $700,047 | $475,413 | $445,204 | $8,357 | $2,175,528 |
| Adam Havey | 2019 | $484,120 | $619,984 | $436,154 | $279,579 | $25,530 | $1,845,367 |
| Adam Havey | 2018 | $480,728 | $499,974 | $359,784 | $310,212 | $8,383 | $1,659,081 |
| Atul Saran | 2020 | $528,803 | $700,047 | $475,413 | $445,204 | $9,565 | $2,159,032 |
| Atul Saran | 2019 | $503,774 | $619,984 | $436,154 | $293,567 | $9,500 | $1,862,979 |
| Atul Saran | 2018 | $488,730 | $527,475 | $379,572 | $293,567 | $8,683 | $1,698,027 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1367644/000136764421000061/ebsi2021asmproxystatement.htm
What are Emergent Biosolutions Inc's Past Insider Trades?
Emergent Biosolutions Inc's most recent insider trade came on November 29, 2022 by Richard S. Lindahl Attorney-In-Fact who sold 1,912 units worth $22.83K . In the last 16 years, insiders at Emergent Biosolutions Inc have sold an estimated value of $238.48M and bought an estimated value of $38.64M worth of shares. Insider trading is most common in May, with the busiest year in 2007. The most active traders at the company are Fuad Elhibri, Director, Daniel Abdunnabi, CEO, and Robert Kramer, President and CEO .
Emergent BioSolutions Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||